CATEGORY Salut, Covid-19, Vacunes
DATE: June 03 2021


The Japanese biopharmacy company Takeda reached in October an agreement with Moderna and the Japanese Ministry of Health, Labour and Welfare to distribute 50 million doses during the first half of 2021 under the TAK-919 name. On 21 May 2021, Takeda announced the approval of the formula by the Japanese Government, and informed that the distribution would immediately start.

Read all the information about Moderna’s vaccine here.

KEYWORDS TAK-919, vaccines